Hydrochloric Acid → (1-{3-Acetyl-5-[2-(4-bromo-phenyl)-2-oxo-ethylcarbamoyl]-imidazolidine-1-carbonyl}-2-methyl-propyl)-carbamic acid methyl ester
反応式
CO[C:3]([CH:5]1[CH2:9][N:8]([C:10](=[O:12])[CH3:11])[CH2:7][N:6]1[C:13](=[O:23])[CH:14]([NH:18][C:19]([O:21][CH3:22])=[O:20])[CH:15]([CH3:17])[CH3:16])=[O:4].[Li+].[OH-].Cl.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.Cl.[NH2:61][CH2:62][C:63]([C:65]1[CH:70]=[CH:69][C:68]([Br:71])=[CH:67][CH:66]=1)=[O:64]>C1COCC1.CO>[CH3:22][O:21][C:19](=[O:20])[NH:18][CH:14]([C:13]([N:6]1[CH:5]([C:3](=[O:4])[NH:61][CH2:62][C:63]([C:65]2[CH:70]=[CH:69][C:68]([Br:71])=[CH:67][CH:66]=2)=[O:64])[CH2:9][N:8]([C:10](=[O:12])[CH3:11])[CH2:7]1)=[O:23])[CH:15]([CH3:16])[CH3:17]参加物
反応物 6
生成物 1
試薬・触媒・溶媒 2
実験手順
1-Acetyl-3-(2-methoxycarbonylamino-3-methyl-butyryl)-imidazolidine-4-carboxylic acid methyl ester (273 mg, 0.829 mmol) was dissolved in THF (1.8 mL) and MeOH (1.2 mL). An aqueous solution of LiOH (34.8 mg, 0.829 mmol) was added and stirring at room temperature was continued. After the hydrolysis was complete, the reaction was neutralized with aqueous HCl (0.83 mL, 1M). The organic solvents were removed in vacuo and the aqueous suspension was frozen and lyophilized. The crude material was used in the next step without further purification. The crude material was dissolved in DMF (3 mL) and HATU (315 mg, 0.829 mmol) and DIEA (106 mg, 0.829 mmol) were added. The reaction was stirred at room temperature for five minutes, after which the amino-(4′bromo) acetophenone hydrochloride salt (207 mg, 0.829 mmol) was added. Stirring at room temperature was continued. After 120 minutes, all volatiles were removed in vacuo and the crude material was dissolved in DCM. The organic layer was washed with aqueous HCl (0.5 M), aqueous lithium chloride solution (5%), brine and was dried over sodium sulfate. Filtration and evaporation of solvents yielded crude product which was purified via silica gel chromatography (eluent EtOAc/hexanes) to yield the product (1-{3-Acetyl-5-[2-(4-bromo-phenyl)-2-oxo-ethylcarbamoyl]-imidazolidine-1-carbonyl}-2-methyl-propyl)-carbamic acid methyl ester (203 mg, 0.397 mmol): LCMS-ESI+: calc'd for C21H27BrN4O6: 511.4 (M+). Found: 511.3/513.2 (M+H+).
後処理
- customThe organic solvents were removed in vacuo
- temperaturethe aqueous suspension was frozen
- customThe crude material was used in the next step without further purification
- dissolutionThe crude material was dissolved in DMF (3 mL)
- stirringThe reaction was stirred at room temperature for five minutes
- stirringStirring at room temperature
- customall volatiles were removed in vacuo
- dissolutionthe crude material was dissolved in DCM
- washThe organic layer was washed with aqueous HCl (0.5 M), aqueous lithium chloride solution (5%), brine
- dry with materialwas dried over sodium sulfate
- filtrationFiltration and evaporation of solvents
- customyielded crude product which
- customwas purified via silica gel chromatography (eluent EtOAc/hexanes)
出典と根拠
- ORDレコード
- ord-b82b2bb6ff674c5eb0383c26cbb35eb9
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08822430B2
反応ノート
読み込み中…